Clinical trial
Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Intraperitoneal Bupivacaine for Pain Relief in Children Undergoing Laparoscopic Herniorrhaphy: a Randomized Controlled Study.
NCT02820610 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dexmedetomidine Versus Magnesium Sulfate as an Adjuvant to Intraperitoneal Bupivacaine for Pain Relief in Children Undergoing Laparoscopic Herniorrhaphy: a Randomized Controlled Study.
- Lead sponsor
- Assiut University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- September 30, 2019
- Enrollment
- 97 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
analgesia